TAG:
genetic testing for
Medicare Ends Coverage for Some Pharmacogenomic Testing
WHAT THE FEDERAL GOVERNMENT giveth with one hand, it will often taketh away with the other hand. It might be argued that this is true of federal support of pharmacogenomic testing — particularly for those tests clinical labor…
Medicare Ends Coverage for Genetic Drug-Sensitivity Tests
CEO SUMMARY: Medicare’s decision to cease covering many pharmacogenomic tests puts as many as 19 million Americans who have genetic variations affecting their response to medications at risk. These medications are commonly prescribed for patients with cardiovascular disease, pain…
September 17, 2012 “Intelligence: Late Breaking Lab News”
Exome sequencing testing for cancer patients is now offered by the Cancer Genetics Laboratory at Baylor College of Medicine (BCM) in Houston, Texas. This clinical testing will be performed using next-generation gene sequencing technology. Pathologists at Baylor are among the first in…
December 19, 2011 “Intelligence: Late Breaking Lab News”
Expanded genetic testing for cancer patients in the United Kingdom is one goal of a new effort by the Stratified Medicine Programme at Cancer Research UK. Officials want to ensure that the right genetic tests are available to support use of new therapeutic drugs for …
CBL Path, Plus Diagnostics, Alpha Innotech, DNA Direct, Humana
NEW PATHOLOGY LABS OPEN ON EAST COAST TIMES MUST BE GOOD for anatomic pathology companies—at least two companies have each announced the opening of a new laboratory facility. On the East Coast, it was CBL Path, Inc., of Rye Brook, New York, which expanded. On May 29, it a…
DeVry University, Retail Walk-In Clinics, NeoGenomics, Clarient, Clinical Lab Partners, Patient ID Theft
MED TECH SHORTAGE CAUSES DEVRY UNIVERSITY TO OFFER MT DEGREE IN RESPONSE TO THE GROWING SHORTAGE of skilled lab scientists and medical technologists, DeVry University of Phoenix, Arizona, is offering a new bachelor’s degree program in Clinical Laboratory Science (…
Lab Director Takes a Stand On Patented Genetic Testing
THIS LETTER APPEARED in the mailbag after our special intelligence briefing on how genetics will transform healthcare and before our look at how high-priced specialty esoteric testing is causing budget headaches for regional labs. (See TDRs, December 30, 2002 and …
“February 26, 2001 Intelligence: Late Breaking Lab News”
Multiplex testing on a single specimen is getting ever closer to the clinical marketplace. On February 19, LINCO Research, Inc. and Luminex Corporation announced an agreement that calls for LINCO to develop, manufacture, and market multianalyte immunoassay kits using…
DNA Diagnostics Market, Kaiser Permanente, TriPath Imaging, LifeScan
DNA DIAGNOSTICS MARKET GROWTH TO BE DOMINATED BY PCR TECHNOLOGY FOR THE YEAR 2000, total DNA diagnostic technology sales were estimated to be $517 million. By 2005, this number should increase to $771 million, a growth rate of 8.4% per year. This is the conclusion of Laura Roth, author of …
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.